|

BC008-1A Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.1

Indications

  • Glioblastoma WHO Grade IV1
  • Glioblastomas (GBM)1
  • Glioma, Recurrent High Grade1
  • Glioma Tumor Recurrence1
  • Glioma1

Other1 trial

BC008-1A Injection for Recurrent CNS WHO G4 Glioma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.